diabetic retinopathy semaglutide attenuates progression via ameliorating retinal vasculopathy and oxidative stress in vivo and in vitro - Cheng - 2025 - Diabetes, Obesity and Metabolism Risk of Diabetic Retinopathy between

Since 2023, there has been rapid growth in the market for weight loss medications, as well as treatments for obesity and diabetes

Please contact your doctor if you have a history of certain eye problems (diabetic retinopathy), a disease of the pancreas (pancreatitis), kidney problems, stomach/intestinal disorders (such as gastroparesis, digestion problems)

Medication expense is a critical component of effective management and must be considered

Additionally, peptides like Glucagon-Like Peptide-1 (GLP-1) have gained attention for their ability to regulate blood sugar levels and slow down gastric emptying

doi: 10.1111/1753-0407.13467 53